
==== Front
Cureus
Cureus
2168-8184
Cureus
2168-8184
Cureus Palo Alto (CA)

10.7759/cureus.67147
Obstetrics/Gynecology
A Rare Case of Placenta Increta at Uterine Fundus
Muacevic Alexander
Adler John R
Naga Rachana Paidi 1
Chennuru Bharathna 1
Kathpalia Sukesh 1
Kshirsagar Shilpa 1
1 Obstetrics and Gynaecology, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed to be University), Pune, IND
Bharathna Chennuru bharathnareddy62@gmail.com
18 8 2024
8 2024
16 8 e6714722 7 2024
18 8 2024
Copyright © 2024, Naga Rachana et al.
2024
Naga Rachana et al.
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article is available from https://www.cureus.com/articles/280907-a-rare-case-of-placenta-increta-at-uterine-fundus
Adherent placenta means a placenta that is not delivered spontaneously or even after manual removal within 30 minutes of baby birth. It is an uncommon and frequently unanticipated event with serious potential health circumstances and it should be managed by the medical team. This case study presents a rare instance of placenta increta in a 25-year-old woman, second gravida, at 36 weeks of gestation, with a history of cesarean section 16 months prior due to chorioamnionitis. The patient presented to the labor room in active labor, and antenatal ultrasound indicated placental implantation on the posterior surface of the upper uterine segment. Given the short inter-delivery interval, an emergency preterm lower segment cesarean section (LSCS) was performed, resulting in the birth of a healthy baby girl weighing 1.8 kg. During surgery, a morbidly adherent placenta was found over the fundus of the uterus. Following consultations with the patient and her relatives, an emergency obstetric total hysterectomy was performed. Intraoperatively, the patient received one unit of packed cell volume (PCV) and, postoperatively, two additional units of PCV and two units of fresh frozen plasma (FFP) were administered. On the third postoperative day, the patient developed right lung consolidation, necessitating a five-day stay in the Obstetric Intensive Care Unit (OBICU). The remaining postoperative period was uneventful, and the patient was discharged on the 10th postoperative day with the healthy infant.

Placenta accreta, including its variants increta and percreta, represents abnormal placental implantation into the uterine wall, a condition whose incidence is rising due to increased cesarean sections and improved imaging detection.

high-risk pregnancy
morbid adherent placenta
obstetric hysterectomy
ceserean section
placenta accreta syndrome
==== Body
pmcIntroduction

Placenta accreta spectrum (PAS) disorders, encompassing placenta accreta, increta, and percreta, are characterized by the abnormal adherence of the placenta to the uterine wall, with varying degrees of invasion into the myometrium. Placenta accreta involves the superficial attachment of the placenta to the myometrium without intervening decidua. Placenta increta denotes deeper invasion into the myometrium, while placenta percreta penetrates through the myometrium and may invade adjacent organs, such as the bladder [1]. The incidence of PAS disorders has been on the rise, primarily due to an increasing number of women undergoing multiple cesarean sections and the enhanced ability to detect these conditions through advanced imaging techniques [2,3].

PAS disorders pose significant risks to both maternal and fetal health due to the high potential for massive obstetric hemorrhage, the need for blood transfusions, and the increased likelihood of hysterectomy [4]. Furthermore, PAS can result in preterm delivery and associated neonatal complications. The increasing prevalence of PAS disorders necessitates heightened awareness and improved diagnostic and management strategies to mitigate these risks [5].

Several risk factors contribute to the development of PAS disorders. The most significant risk factor is a history of cesarean delivery. The risk of PAS increases with the number of prior cesarean sections, with a reported incidence of up to 67% in women with placenta previa and four or more cesarean sections [6]. Other risk factors include placenta previa, prior uterine surgery (such as dilation and curettage, manual removal of the placenta, synechiolysis, or myomectomy), increasing maternal age, high parity, and assisted reproductive technologies [7]. The presence of these risk factors necessitates careful antenatal monitoring and consideration of PAS in the differential diagnosis.

The diagnosis of PAS disorders is challenging and often not confirmed until delivery when attempts at manual removal of the placenta fail. However, antenatal diagnosis is crucial for planning appropriate management to reduce maternal and fetal morbidity and mortality. Ultrasound, particularly transvaginal ultrasound (TVS), is the primary imaging modality used for the diagnosis of PAS. Key ultrasound findings include the presence of placental lacunae, loss of the retroplacental clear space, and abnormal color Doppler patterns indicating increased vascularity at the placental-myometrial interface [8]. Magnetic resonance imaging (MRI) can provide additional information, especially in cases where ultrasound findings are inconclusive. MRI features indicative of PAS include uterine bulging, heterogeneous signal intensity within the placenta, and dark intra-placental bands on T2-weighted imaging [9].

Histopathological examination remains the gold standard for confirming PAS, revealing features such as partial or total absence of the decidua basalis and imperfect development of the fibrinoid layer (Nitabuch’s layer) [10]. Elevated levels of alpha-fetoprotein (AFP) have also been observed in PAS cases, although this is not a definitive diagnostic marker [11]. The cornerstone of management is timely cesarean hysterectomy, which entails delivery of the infant followed by removal of the uterus with the placenta in situ to prevent hemorrhage. Preoperative preparation includes patient counseling and consent for arterial catheterization to occlude pelvic blood flow and reduce intraoperative bleeding [12]. Intraoperative and postoperative management focuses on controlling hemorrhage and supporting maternal hemodynamics through transfusions and critical care support as needed [13].

In conclusion, the rising incidence of PAS disorders underscores the importance of early identification and management to improve maternal and fetal outcomes. Women with known risk factors, particularly those with a history of multiple cesarean sections, should undergo thorough antenatal screening for PAS, regardless of the placental site. Comprehensive management strategies tailored to the individual patient's needs are essential to mitigate the severe complications associated with these disorders [14].

Case presentation

A 25-year-old multiparous woman with gravida2 parity1 living1 (G2P1L1) at 36 weeks of gestation, with a history of cesarean section performed 16 months prior for chorioamnionitis, presented to the labor and delivery unit experiencing active labor pains. Antenatal ultrasonography revealed the placenta implanted on the posterior surface of the upper uterine segment. Given the short inter-delivery interval, an emergency preterm lower segment cesarean section (LSCS) with pfannenstiel incision under spinal anesthesia, further converted to general anesthesia, was indicated and subsequently performed.

Intraoperatively, the placenta was found to be morbidly adherent to the fundus of the uterus (Figure 1), consistent with a diagnosis of placenta increta. Following a thorough discussion with the patient and her family regarding expectant and surgical management options, an emergency obstetric total hysterectomy was conducted to effectively manage the placenta accreta syndrome (PAS). Intraoperative management included the transfusion of one unit of packed cell volume (PCV).

Figure 1 Intraoperatively, the placenta was found over the fundus of the uterus on the posterior surface, which was morbidly adherent.

Postoperatively, the patient required additional transfusions of two units of PCV and two units of fresh frozen plasma (FFP). On the third postoperative day, she developed right lung consolidation, necessitating admission to the Obstetric Intensive Care Unit (OBICU) for five days for intensive monitoring and treatment. The remainder of the postoperative period was uneventful, and the patient was discharged on the 10th postoperative day in stable condition, along with her healthy newborn, a female infant weighing 1.8 kg.

Histopathological examination of the resected uterus confirmed the diagnosis of placenta increta (Figure 2). Sections from the endometrium demonstrated the presence of chorionic villi invading the myometrium without intervening decidua, and hypertrophy of the myometrial muscle was observed. This case underscores the critical importance of early diagnosis and timely surgical intervention in managing morbidly adherent placentation to mitigate the associated maternal and fetal risks.

Figure 2 The section from endometrium shows the presence of chorionic villi invading myometrium without intervening decidua, suggestive of placenta increta. Myometrium shows the hypertrophy of the muscle.

Discussion

Placenta increta, a severe variant of the placenta accreta spectrum (PAS), presents a significant challenge in obstetric management due to its deep invasion into the myometrium without reaching the uterine serosa [1]. The condition's increasing incidence is linked to the rising rates of cesarean sections and advanced maternal age, necessitating improved diagnostic and management strategies [15].

The patient's history of a cesarean section performed 16 months prior was a significant risk factor for placenta increta. The risk of PAS disorders escalates with the number of prior cesarean sections, with studies indicating a risk increase from 3% with one previous cesarean to 67% with four or more [6]. Other contributing factors include placenta previa, previous uterine surgeries such as dilation and curettage or myomectomy, high parity, and the use of assisted reproductive technologies [7,16]. These risk factors highlight the need for vigilant prenatal care and consideration of PAS in patients with such histories.

The management of PAS, particularly placenta increta, often necessitates a multidisciplinary approach. In this case, an emergency obstetric total hysterectomy was performed following intraoperative identification of a morbidly adherent placenta over the uterine fundus. This approach is supported by current guidelines, which recommend cesarean hysterectomy as the definitive treatment to prevent life-threatening hemorrhage [12,17]. The importance of a prepared and coordinated surgical team cannot be overstated, as prompt action and adequate intraoperative support are crucial for patient outcomes.

Intraoperative and postoperative management focuses on controlling hemorrhage and maintaining hemodynamic stability. The patient in this case required intraoperative and postoperative transfusions of packed cell volume (PCV) and fresh frozen plasma (FFP), highlighting the need for readily available blood products and a well-structured transfusion protocol [18]. The development of right lung consolidation postoperatively underscores the necessity for vigilant monitoring for potential complications, including respiratory issues, which are common in patients undergoing extensive surgical procedures [5].

Histopathological examination is essential for confirming the diagnosis of placenta increta. The presence of chorionic villi invading the myometrium without intervening decidua, along with hypertrophy of the myometrial muscle, confirms the diagnosis. These histological findings are critical for guiding future management, particularly in advising patients about risks in subsequent pregnancies [19].

Recent advancements in the management of PAS include interventional radiology techniques, such as preoperative arterial catheterization, to occlude pelvic blood flow and reduce intraoperative bleeding. However, the effectiveness and safety of these techniques require further research and the development of standardized protocols.

This case highlights several critical considerations in managing PAS disorders. First, early and accurate antenatal diagnosis is crucial for planning appropriate management strategies and reducing the need for emergent interventions. Second, a multidisciplinary approach involving obstetricians, anesthesiologists, and interventional radiologists is essential for comprehensive care. Third, patient education and counseling are vital, particularly for women with known risk factors, to ensure they understand the potential risks and the importance of regular antenatal monitoring.

In summary, placenta increta, as part of the PAS disorder, presents significant challenges in obstetric care. The increasing incidence necessitates heightened awareness and improved diagnostic and management strategies. Early diagnosis through advanced imaging, coupled with a multidisciplinary management approach, is critical in mitigating the severe maternal and fetal complications associated with PAS disorders. Further research is needed to refine diagnostic criteria and develop standardized management protocols to improve outcomes for affected women [18,20].

Conclusions

Placenta increta, as a component of the placenta accreta spectrum (PAS) disorders, presents significant challenges in obstetric care due to its association with severe maternal morbidity and potential mortality. This case highlights the critical importance of early and accurate antenatal diagnosis through advanced imaging techniques such as ultrasound and MRI, which facilitate meticulous planning and timely intervention. The management of PAS, particularly placenta increta, often necessitates a multidisciplinary approach, involving obstetricians, anesthesiologists, and interventional radiologists to address the complexities of the condition effectively. Emergency obstetric hysterectomy remains the cornerstone of treatment to prevent life-threatening hemorrhage. Adequate intraoperative and postoperative care, including blood transfusion protocols and vigilant monitoring for complications, is essential to ensure favorable outcomes. This case underscores the necessity for heightened awareness, improved diagnostic strategies, and comprehensive management protocols to mitigate the risks associated with PAS disorders. Further research and development of standardized guidelines are imperative to enhance the care and outcomes for affected women, ensuring that those at risk receive appropriate antenatal surveillance and intervention.

Disclosures

Author Contributions

Human subjects: All authors have confirmed that this study did not involve human participants or tissue.

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following:

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Concept and design:  Paidi Naga Rachana, Bharathna Chennuru, Sukesh Kathpalia, Shilpa Kshirsagar

Acquisition, analysis, or interpretation of data:  Paidi Naga Rachana, Bharathna Chennuru, Sukesh Kathpalia, Shilpa Kshirsagar

Drafting of the manuscript:  Paidi Naga Rachana, Bharathna Chennuru, Sukesh Kathpalia, Shilpa Kshirsagar

Critical review of the manuscript for important intellectual content:  Paidi Naga Rachana, Bharathna Chennuru, Sukesh Kathpalia, Shilpa Kshirsagar

Supervision:  Paidi Naga Rachana, Bharathna Chennuru, Sukesh Kathpalia, Shilpa Kshirsagar
==== Refs
References

1 Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis Am J Obstet Gynecol Jauniaux E Bhide A 27 36 217 2017 28268196
2 The histomorphological spectrum of placenta in growth restricted fetuses in a tertiary care centre in South India Iran J Pathol Sundari Amirthakatesan A Devi Chandramohan S Gurusamy UM 12 23 18 2023 37383163
3 Placenta percreta: rare presentation of haemorrhage in the second trimester BMJ Case Rep Siwatch S Chopra S Suri V Gupta N 0 2013 2013
4 Morbidly adherent placenta treatments and outcomes Obstet Gynecol Bailit JL Grobman WA Rice MM 683 689 125 2015 25730233
5 Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study PLoS One Fitzpatrick KE Sellers S Spark P Kurinczuk JJ Brocklehurst P Knight M 0 7 2012
6 Abnormal placentation: twenty-year analysis Am J Obstet Gynecol Wu S Kocherginsky M Hibbard JU 1458 1461 192 2005 15902137
7 Maternal morbidity associated with multiple repeat cesarean deliveries Obstet Gynecol Silver RM Landon MB Rouse DJ 1226 1232 107 2006 16738145
8 Sonographic detection of placenta accreta in the second and third trimesters of pregnancy Am J Obstet Gynecol Comstock CH Love JJ Jr Bronsteen RA Lee W Vettraino IM Huang RR Lorenz RP 1135 1140 190 2004 15118654
9 Prenatal identification of invasive placentation using magnetic resonance imaging: systematic review and meta-analysis Ultrasound Obstet Gynecol D'Antonio F Iacovella C Palacios-Jaraquemada J Bruno CH Manzoli L Bhide A 8 16 44 2014 24515654
10 Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast Placenta Tantbirojn P Crum CP Parast MM 639 645 29 2008 18514815
11 Fetal imaging: executive summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Institute of Ultrasound in Medicine, American College of Obstetricians and Gynecologists, American College of Radiology, Society for Pediatric Radiology, and Society of Radiologists in Ultrasound Fetal Imaging Workshop Am J Obstet Gynecol Reddy UM Abuhamad AZ Levine D Saade GR 387 397 210 2014 24793721
12 Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta Obstet Gynecol Warshak CR Ramos GA Eskander R 65 69 115 2010 20027036
13 Placenta accreta Am J Obstet Gynecol Belfort MA 430 439 203 2010 21055510
14 Optimal management strategies for placenta accreta BJOG Eller AG Porter TF Soisson P Silver RM 648 654 116 2009 19191778
15 Clinical risk factors for placenta previa-placenta accreta Am J Obstet Gynecol Miller DA Chollet JA Goodwin TM 210 214 177 1997 9240608
16 The management of placenta percreta: conservative and operative strategies Am J Obstet Gynecol O'Brien JM Barton JR Donaldson ES 1632 1638 175 1996 8987952
17 Undiagnosed placenta praevia percreta: A rare case report and review of management Niger Postgrad Med J Okunowo AA Ohazurike EO Habeebu-Adeyemi FM 61 64 26 2019 30860201
18 Abnormally invasive placenta - prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries BJOG Thurn L Lindqvist PG Jakobsson M 1348 1355 123 2016 26227006
19 Individual decisions in placenta increta and percreta: a case series J Perinat Med Chantraine F Nisolle M Petit P Schaaps JP Foidart JM 265 270 40 2012 22505505
20 FIGO consensus guidelines on placenta accreta spectrum disorders: nonconservative surgical management Int J Gynaecol Obstet Allen L Jauniaux E Hobson S Papillon-Smith J Belfort MA 281 290 140 2018 29405317
